UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 38

Sortiert nach

Acute myocarditis with autoimmune features: one-year follow-up with CMR

Heart and vessels, 2022-02, Vol.37 (2), p.291-299

2022

Volltextzugriff (PDF)

Regulatory T-cell dysfunctions are associated with increase in tumor necrosis factor α in autoimmune hemolytic anemia and participate in Th17 polarization

Haematologica (Roma), 2024-02, Vol.109 (2), p.444

2024

Volltextzugriff (PDF)

Targeted treatment in Takayasu arteritis

Joint, bone, spine : revue du rhumatisme, 2022-03, Vol.89 (2), p.105338-105338, Article 105338

2022

Volltextzugriff (PDF)

Pro-angiogenic changes of T-helper lymphocytes in hereditary hemorrhagic telangiectasia

Frontiers in immunology, 2023, Vol.14, p.1321182-1321182

2023

Volltextzugriff (PDF)

Full-field optical coherence tomography for the diagnosis of giant cell arteritis

PloS one, 2020-08, Vol.15 (8), p.e0234165-e0234165

2020

Volltextzugriff (PDF)

PET/CT of cranial arteries for a sensitive diagnosis of giant cell arteritis

Rheumatology, 2023-04, Vol.62 (4), p.1568-1575

2023

Volltextzugriff (PDF)

Heamatological malignancies in giant cell arteritis: a French population-based study

Rheumatology (Oxford, England), 2021-11, Vol.60 (11), p.5408-5412

2021

Volltextzugriff (PDF)

Mimickers of Large Vessel Giant Cell Arteritis

Journal of clinical medicine, 2022-01, Vol.11 (3), p.495

2022

Volltextzugriff (PDF)

Human monocyte-derived suppressive cells (HuMoSC) for cell therapy in giant cell arteritis

Frontiers in immunology, 2023-02, Vol.14, p.1137794-1137794

2023

Volltextzugriff (PDF)

Neointimal myofibroblasts contribute to maintaining Th1/Tc1 and Th17/Tc17 inflammation in giant cell arteritis

Journal of autoimmunity, 2024-01, Vol.142, p.103151-103151, Article 103151

2024

Volltextzugriff (PDF)

Predictive Factors of Giant Cell Arteritis in Polymyalgia Rheumatica Patients

Journal of clinical medicine, 2022-12, Vol.11 (24), p.7412

2022

Volltextzugriff (PDF)

Temporal Artery Vascular Diseases

Journal of clinical medicine, 2022-01, Vol.11 (1), p.275

2022

Volltextzugriff (PDF)

Human Monocyte-Derived Suppressor Cell Supernatant Induces Immunoregulatory Effects and Mitigates xenoGvHD

Frontiers in immunology, 2022-03, Vol.13, p.827712-827712

2022

Volltextzugriff (PDF)

Treatment of giant cell arteritis

La Presse médicale (1983), 2019-09

2019

Volltextzugriff (PDF)

Mucosal-associated invariant T cells in Giant Cell Arteritis

Journal of autoimmunity, 2021-07, Vol.121, p.102652-102652, Article 102652

2021

Volltextzugriff (PDF)

Efficiency of human monocyte-derived suppressor cell-based treatment in graft-versus-host disease prevention while preserving graft-versus-leukemia effect

Oncoimmunology, 2021-01, Vol.10 (1), p.1880046

2021

Volltextzugriff (PDF)

Prognostic value of 18 FDG-PET at diagnosis and follow-up in giant cell arteritis: An observational restrospective study

European journal of internal medicine, 2024-08, Vol.126, p.69-76

2024

Volltextzugriff (PDF)

T-cell immune response predicts the risk of critical SARS-Cov2 infection in hospitalized COVID-19 patients

European journal of internal medicine, 2022-08, Vol.102, p.104-109

2022

Volltextzugriff (PDF)

Myocardial infarction during giant cell arteritis: A cohort study

European journal of internal medicine, 2021-07, Vol.89, p.30-38

2021

Volltextzugriff (PDF)

Antiplatelet Antibodies Do Not Predict the Response to Intravenous Immunoglobulins during Immune Thrombocytopenia

Journal of clinical medicine, 2020-06, Vol.9 (6), p.1998

2020

Volltextzugriff (PDF)

Diagnostic accuracy of serum biomarkers to identify giant cell arteritis in patients with polymyalgia rheumatica

Rheumatic & musculoskeletal diseases open, 2024-08, Vol.10 (3), p.e004488

2024

Volltextzugriff (PDF)

New Insights into the Pathogenesis of Giant Cell Arteritis: Mechanisms Involved in Maintaining Vascular Inflammation

Journal of clinical medicine, 2022-05, Vol.11 (10), p.2905

2022

Volltextzugriff (PDF)

Improvement of Treg immune response after treatment with tocilizumab in giant cell arteritis

Clinical & translational immunology, 2021, Vol.10 (9), p.e1332-n/a

2021

Volltextzugriff (PDF)

Increased neopterin in cerebrospinal fluid in active adult neurohistiocytosis

Hematological oncology, 2023-10, Vol.41 (4), p.762-767

2023

Volltextzugriff (PDF)

Maladies systémiques et médecine vasculaire en 2022 : ce que nous apportent les nouveaux Protocoles Nationaux de Diagnostic et de soins (PNDS). L’artérite à cellules géantes

Journal de médecine vasculaire, 2022-03, Vol.47, p.S18-S18

2022

Volltextzugriff (PDF)

1 – 25 von 38

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(33)
Mit Volltextzugriff
(35)

Publikationsform

Sprache

Englisch
(29)
Französisch
(10)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Acute myocarditis with autoimmune features: one-year follow-up with CMR

Regulatory T-cell dysfunctions are associated with increase in tumor necrosis factor α in autoimmune hemolytic anemia and participate in Th17 polarization

Targeted treatment in Takayasu arteritis

Pro-angiogenic changes of T-helper lymphocytes in hereditary hemorrhagic telangiectasia

Full-field optical coherence tomography for the diagnosis of giant cell arteritis

PET/CT of cranial arteries for a sensitive diagnosis of giant cell arteritis

Heamatological malignancies in giant cell arteritis: a French population-based study

Mimickers of Large Vessel Giant Cell Arteritis

Human monocyte-derived suppressive cells (HuMoSC) for cell therapy in giant cell arteritis

Neointimal myofibroblasts contribute to maintaining Th1/Tc1 and Th17/Tc17 inflammation in giant cell arteritis

Predictive Factors of Giant Cell Arteritis in Polymyalgia Rheumatica Patients

Temporal Artery Vascular Diseases

Human Monocyte-Derived Suppressor Cell Supernatant Induces Immunoregulatory Effects and Mitigates xenoGvHD

Treatment of giant cell arteritis

Mucosal-associated invariant T cells in Giant Cell Arteritis

Efficiency of human monocyte-derived suppressor cell-based treatment in graft-versus-host disease prevention while preserving graft-versus-leukemia effect

Prognostic value of 18 FDG-PET at diagnosis and follow-up in giant cell arteritis: An observational restrospective study

T-cell immune response predicts the risk of critical SARS-Cov2 infection in hospitalized COVID-19 patients

Myocardial infarction during giant cell arteritis: A cohort study

Antiplatelet Antibodies Do Not Predict the Response to Intravenous Immunoglobulins during Immune Thrombocytopenia

Diagnostic accuracy of serum biomarkers to identify giant cell arteritis in patients with polymyalgia rheumatica

New Insights into the Pathogenesis of Giant Cell Arteritis: Mechanisms Involved in Maintaining Vascular Inflammation

Improvement of Treg immune response after treatment with tocilizumab in giant cell arteritis

Increased neopterin in cerebrospinal fluid in active adult neurohistiocytosis

Maladies systémiques et médecine vasculaire en 2022 : ce que nous apportent les nouveaux Protocoles Nationaux de Diagnostic et de soins (PNDS). L’artérite à cellules géantes

Suchergebnisse filtern